Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Think twice before tapering opioids in some patients

Casey Grover, MD and Lee Goldman, MD
Conditions
February 4, 2018
Share
Tweet
Share

Bill is a 58-year-old male with a history of head and neck cancer as well as chronic low back pain who presents to his new primary care doctor for a routine checkup and visit for a medication refill. He works in construction and has been on chronic opioid therapy after his cancer — with a stable dose of 15 mg of oxycodone for over five years.

At his new primary care visit, after a few meet and greet pleasantries, his new primary care doctor discusses his current medication regimen with him — ibuprofen 400mg TID and oxycodone 15mg BID. His physician expresses significant concern with his medication regimen, telling Bill that “it’s against the rules” to continue prescribing opioids for him — despite the fact that he’s been on this dose for several years.

She prescribes an oxycodone taper for him and requests he return to her office in two weeks for a re-evaluation.

Bill, not wanting to be a problem, takes his taper as prescribed for the first few days. However, as he’s been on opioids for over five years, he begins feeling sick — nausea, vomiting, malaise, and irritability. He tries to go back to his old dose but runs out of oxycodone. While trying to work at a construction site, Bill is having trouble completing his tasks and drops a few expensive objects.

After a few harsh words from his supervisor, Bill realizes he cannot work given how he feels and contacts his old oncologist for help. His oncologist provides him with a small prescription for oxycodone, which he fills. Bill feels better and is able to get through to his primary care follow-up visit.

Bill lets his new primary care doctor know about what happened: the withdrawal, not being able to work and how he had to get a refill from his oncologist. The doctor expresses extreme concern
about his “drug seeking” and “doctor shopping” and tells him he is fired as a patient. He is discharged from the practice.

Out of opioids and feeling sick again, he presents to the emergency department with a chief complaint of “medication refill.”

How could this have been avoided? Was his primary care provider too quick to vilify his chronic, stable opioid regimen and start him on an opioid taper? Was there any reason to taper him?

America clearly has a problem with opioids. Going forward, it is best practice to avoid starting an opiate naïve patient on opiates for chronic nonterminal pain. However, what do we do with patients like Bill? There is clearly a group of patients who have been previously prescribed opioids for chronic pain and are dependent on opioids. While some of these patients have struggled with addiction to their opioids, others — like Bill — have been stable on a particular dose of opioids without any problems.

When confronted with such patients on chronic opioid therapy, physicians must consider the risk of addiction or medication misuse when choosing whether or not to taper or discontinue opioid therapy. Providers should consider whether or not any of the four major risk factors for substance abuse are present: a current substance use disorder, a history of substance abuse, a family history of substance abuse and severe/untreated mental illness.

Attention should also be paid to signs of patients developing addiction to chronic opioid therapy: excessively escalating doses, obtaining medications from multiple prescribers in an irregular fashion, requesting early refills and losing prescriptions — to
name a few.

It is important to realize that not every patient on long-term opioid therapy is an addict — and that some people can be stable, without addiction, on long-term opioid therapy. Patients without major risk factors for addiction and who do not show signs of developing addiction could be just simply maintained on the opioid regimen that works for them, with regular check-ins to ensure that they are still doing well with their treatment. While long-term opioid therapy for a non-terminal pain syndrome is clearly not desirable, abruptly tapering or discontinuing opioid therapy in such patients — without first developing a plan with the patient or other providers – is bound to cause problems with uncontrolled pain and withdrawal, as we saw with our patient Bill.

Casey Grover is an emergency physician. Lee Goldman is a family physician.

ADVERTISEMENT

Image credit: Shutterstock.com

Prev

Every medical student deserves to be educated in an anti-bias learning environment

February 4, 2018 Kevin 1
…
Next

A drug problem in rural Georgia

February 4, 2018 Kevin 0
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Every medical student deserves to be educated in an anti-bias learning environment
Next Post >
A drug problem in rural Georgia

ADVERTISEMENT

Related Posts

  • How the war on opioids has harmed some patients

    Angelika Byczkowski
  • Blame the pain, not the opioids

    Angelika Byczkowski
  • People who take opioids are the AIDS patients of today

    Heather Finlay-Morreale, MD
  • Are patients using social media to attack physicians?

    David R. Stukus, MD
  • Patients in Sweden received fewer post-op opioids. Why is that?

    Richard Young, MD
  • Why staying ahead of your pain with opioids is the wrong advice

    Myles Gart, MD

More in Conditions

  • Why transgender health care needs urgent reform and inclusive practices

    Angela Rodriguez, MD
  • Why the Sean Combs trial is a wake-up call for HIV prevention

    Catherine Diamond, MD
  • New surge in misleading ads about diabetes on social media poses a serious health risk

    Laura Syron
  • mRNA post vaccination syndrome: Is it real?

    Harry Oken, MD
  • The critical role of nurse practitioners in colorectal cancer screening

    Elisabeth Evans, FNP
  • Are we repeating the statin playbook with lipoprotein(a)?

    Larry Kaskel, MD
  • Most Popular

  • Past Week

    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Closing the diversity gap in Parkinson’s research

      Vicky Chan | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Brooklyn hepatitis C cluster reveals hidden dangers in outpatient clinics

      Don Weiss, MD, MPH | Policy
    • The truth in medicine: Why connection matters most

      Ryan Nadelson, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why trust and simplicity matter more than buzzwords in hospital AI

      Rafael Rolon Rivera, MD | Tech
    • Putting food allergy safety on the menu [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 4 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Closing the diversity gap in Parkinson’s research

      Vicky Chan | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Brooklyn hepatitis C cluster reveals hidden dangers in outpatient clinics

      Don Weiss, MD, MPH | Policy
    • The truth in medicine: Why connection matters most

      Ryan Nadelson, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why trust and simplicity matter more than buzzwords in hospital AI

      Rafael Rolon Rivera, MD | Tech
    • Putting food allergy safety on the menu [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Think twice before tapering opioids in some patients
4 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...